While Repligen Corp has underperformed by -0.54%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, RGEN fell by -19.53%, with highs and lows ranging from $211.13 to $113.50, whereas the simple moving average fell by -3.26% in the last 200 days.
On December 17, 2024, Canaccord Genuity started tracking Repligen Corp (NASDAQ: RGEN) recommending Hold. A report published by Wolfe Research on November 14, 2024, Initiated its previous ‘Peer Perform’ rating for RGEN. Wells Fargo also rated RGEN shares as ‘Overweight’, setting a target price of $180 on the company’s shares in an initiating report dated August 28, 2024. Deutsche Bank June 26, 2024d the rating to Buy on June 26, 2024, and set its price target from $180 to $155. Guggenheim initiated its ‘Neutral’ rating for RGEN, as published in its report on June 18, 2024. Wells Fargo also rated the stock as ‘Overweight’.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Analysis of Repligen Corp (RGEN)
Further, the quarter-over-quarter increase in sales is 9.69%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Repligen Corp’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -0.41% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 8.76, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and RGEN is recording an average volume of 596.99K. On a monthly basis, the volatility of the stock is set at 4.00%, whereas on a weekly basis, it is put at 4.67%, with a loss of -6.06% over the past seven days. Furthermore, long-term investors anticipate a median target price of $192.23, showing growth from the present price of $146.54, which can serve as yet another indication of whether RGEN is worth investing in or should be passed over.
How Do You Analyze Repligen Corp Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 6.96%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 99.83% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
RGEN shares are owned by institutional investors to the tune of 99.83% at present.
